Literature DB >> 26547140

Effects of periodontal treatment on inflammation and oxidative stress markers in patients with metabolic syndrome.

G Torumtay1, F Y Kırzıoğlu1, M Öztürk Tonguç1, B Kale2, M Calapoğlu3, H Orhan4.   

Abstract

BACKGROUND AND
OBJECTIVE: Metabolic syndrome (MetS) is a combination of risk factors (e.g. impaired glucose tolerance, hypertension, and dyslipidaemia) that significantly contribute to the development of cardiovascular diseases. The aim of the study was to compare the effects of nonsurgical periodontal treatment (NSPT) on inflammatory and oxidative stress markers in individuals with MetS and systemically healthy (SH) who were chronic periodontitis (CP).
MATERIAL AND METHODS: A total of 50 patients with chronic periodontitis (25 with MetS and 25 SH) were included. Clinical periodontal measurements were recorded, and serum and whole-saliva samples were collected from all patients at baseline, and 3 and 6 mo following NSPT. The levels of fasting plasma glucose, glycated haemoglobin (HbA1c), triglyceride (TRG), total cholesterol, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol were analysed. The levels of high-sensitivity C-reactive protein (hs-CRP), interleukin (IL)-6 and IL-10 were determined using ELISA kits, and total oxidant status (TOS), total antioxidant capacity (TAC) and oxidative stress index (OSI) levels were measured.
RESULTS: After NSPT, significant and similar improvements of all periodontal parameters were observed in both groups compared with baseline measurements. There were decreases in the levels of serum hs-CRP and IL-6, whereas increases in serum IL-10 were found in both groups, at all time points. Serum TOS and OSI showed no significant change in either group at any time point. Compared with the SH group, serum TAC levels were higher in the MetS group at baseline but lower at the 3-mo time-point. There was no difference in TAC levels between the groups at 6 mo. Saliva IL-6 was higher in the MetS group than the SH group at all time points. The levels of IL-6 and OSI in saliva decreased following NSPT in both groups, whereas salivary TAC concentrations increased. In the MetS group, TRG and HbA1c levels decreased significantly at 3 mo.
CONCLUSION: NSPT decreased oxidative stress and the inflammatory status of patients with MetS and chronic periodontitis. Although similar periodontal improvements were achieved in both groups, the decreases in levels of hs-CRP and IL-6 in the MetS group did not reach the levels in the SH group. Based on these results, NSPT could be more effective in the control of systemic inflammation in patients with MetS in the short-term.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  chronic periodontitis; cytokines; metabolic syndrome; oxidative stress

Mesh:

Substances:

Year:  2015        PMID: 26547140     DOI: 10.1111/jre.12328

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  13 in total

1.  Integrated biomarker profiling of smokers with periodontitis.

Authors:  Radhakrishnan Nagarajan; Mohanad Al-Sabbagh; Dolph Dawson; Jeffrey L Ebersole
Journal:  J Clin Periodontol       Date:  2017-02-02       Impact factor: 8.728

2.  Effect of periodontal disease on oxidative stress markers in patients with atherosclerosis.

Authors:  Aysegul Sari; Vedat Davutoglu; Emrullah Bozkurt; Ibrahim Levent Taner; Kamile Erciyas
Journal:  Clin Oral Investig       Date:  2021-08-20       Impact factor: 3.573

Review 3.  Effect of periodontal treatments on blood pressure.

Authors:  Yuxue Luo; Huilin Ye; Wei Liu; Zongkai Lv; Yuanyuan Jia; Chunjie Li; Yifan Zhang
Journal:  Cochrane Database Syst Rev       Date:  2021-12-12

4.  An umbrella review of systematic reviews examining the relationship between type 2 diabetes and periodontitis: Position paper from the Canadian Dental Hygienists Association.

Authors:  Salme E Lavigne; Jane L Forrest
Journal:  Can J Dent Hyg       Date:  2021-02-15

5.  Effect of Supragingival Irrigation with Aerosolized 0.5% Hydrogen Peroxide on Clinical Periodontal Parameters, Markers of Systemic Inflammation, and Morphology of Gingival Tissues in Patients with Periodontitis.

Authors:  Gediminas Žekonis; Jonas Žekonis; Alvydas Gleiznys; Viktorija Noreikienė; Ingrida Balnytė; Renata Šadzevičienė; Julija Narbutaitė
Journal:  Med Sci Monit       Date:  2016-10-15

6.  GC Gene Polymorphisms and Vitamin D-Binding Protein Levels Are Related to the Risk of Generalized Aggressive Periodontitis.

Authors:  Wenli Song; Xian'e Wang; Yu Tian; Xin Zhang; Ruifang Lu; Huanxin Meng
Journal:  Int J Endocrinol       Date:  2016-11-28       Impact factor: 3.257

Review 7.  Oxidative Stress and Antioxidants in the Diagnosis and Therapy of Periodontitis.

Authors:  L'ubomíra Tóthová; Peter Celec
Journal:  Front Physiol       Date:  2017-12-14       Impact factor: 4.566

8.  Effect of periodontal therapy with systemic antimicrobials on parameters of metabolic syndrome: A randomized clinical trial.

Authors:  Sergio Bizzarro; Ubele van der Velden; Wijnand J Teeuw; Victor E A Gerdes; Bruno G Loos
Journal:  J Clin Periodontol       Date:  2017-07-12       Impact factor: 8.728

9.  The effects of ginger supplementation on inflammatory, antioxidant, and periodontal parameters in type 2 diabetes mellitus patients with chronic periodontitis under non-surgical periodontal therapy. A double-blind, placebo-controlled trial.

Authors:  Ahmad Zare Javid; Hadi Bazyar; Hasan Gholinezhad; Mehran Rahimlou; Homeira Rashidi; Parvin Salehi; Mohammad Hosein Haghighi-Zadeh
Journal:  Diabetes Metab Syndr Obes       Date:  2019-09-06       Impact factor: 3.168

10.  Diagnostic value of salivary CRP and IL-6 in patients undergoing anti-TNF-alpha therapy for rheumatic disease.

Authors:  Dorota Sikorska; Zofia Orzechowska; Rafał Rutkowski; Anna Prymas; Marta Mrall-Wechta; Daria Bednarek-Hatlińska; Magdalena Roszak; Anna Surdacka; Włodzimierz Samborski; Janusz Witowski
Journal:  Inflammopharmacology       Date:  2018-07-24       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.